Amicus Therapeutics Gets European Commission Approval For Galafold in Patients With Fabry Disease
May 31, 2016 at 10:55 AM EDT
Amicus Therapeutics (Nasdaq: FOLD) revealed that the European Commission has granted full approval for its oral small molecule ...